THE INFLUENCE OF CYTOGENETIC ABNORMALITIES ON TREATMENT OUTCOME AFTERINTENSIVE ANTILEUKEMIC THERAPY FOR PATIENTS WITH HIGH-RISK MDS AND AML FOLLOWING MDS

DEWITTE,"SUCIU S BOOGAERTS M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A WEIJERMANS P MANDELLI F AMADORI S JEHN U MUUS P DEMUYNCK H DARDENNE M WILLEMZE R GRATWOHL A APPERLEY J

S. Dewitte,"suciu et al., THE INFLUENCE OF CYTOGENETIC ABNORMALITIES ON TREATMENT OUTCOME AFTERINTENSIVE ANTILEUKEMIC THERAPY FOR PATIENTS WITH HIGH-RISK MDS AND AML FOLLOWING MDS, Blood, 88(10), 1996, pp. 1806-1806

NO

Hematology

Blood → ACNP

00064971

88

10

1996

1

1

1806 - 1806

ISI

0006-4971(1996)88:10<1806:TIOCAO>2.0.ZU;2-5